Comparison of PD-L1 expression before and after neoadjuvant chemoradiation or chemotherapy in stage III non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Koenig, D. [1 ]
Prince, S. Savic [2 ]
Trachsel, B. [3 ]
Hayoz, S. [3 ]
Pless, M. [4 ]
机构：
[1] Univ Hosp Basel, Med Oncol Dept, Basel, Switzerland
[2] Univ Hosp Basel, Inst Pathol & Med Genet, Pathol Dept, Basel, Switzerland
[3] SAKK, Swiss Grp Clin Canc Res, Bern, Switzerland
[4] KSW Kantonsspital Winterthur, Med Oncol & Tumor Ctr, Winterthur, Switzerland
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5P
引用
收藏
页码：S1376 / S1376
页数：1
相关论文
共 50 条
  • [41] PD-L1 expression is associated with advanced non-small cell lung cancer
    Chen, Zhiquan
    Mei, Jiandong
    Liu, Lunxu
    Wang, Guochen
    Li, Zuosheng
    Hou, Jingpu
    Zhang, Qiuyang
    You, Zongbing
    Zhang, Liu
    ONCOLOGY LETTERS, 2016, 12 (02) : 921 - 927
  • [42] Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer
    Montero, M. Angeles
    Aricak, Ozan
    Kis, Lorand
    Yoshikawa, Akira
    De Petris, Luigi
    Grundberg, Oscar
    Pham, Hoa H. N.
    Roden, Anja C.
    Fukuoka, Junya
    Attanoos, Richard
    Guijarro, Ricardo
    Alarcon, Felix
    Lindstrom, Kati
    Ortiz-Villalon, Cristian
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2021, 51
  • [43] Results of Surgical Treatment After Neoadjuvant Chemotherapy for Stage III Non-Small Cell Lung Cancer
    Angelo Carretta
    Paola Ciriaco
    Giulio Melloni
    Imad Sayed
    Alessandro Bandiera
    Luca Ferla
    Armando Puglisi
    Piero Zannini
    World Journal of Surgery, 2008, 32 : 2636 - 2642
  • [44] MYC expression correlates with PD-L1 expression in non-small cell lung cancer
    Kim, Eun Young
    Kim, Arum
    Kim, Se Kyu
    Chang, Yoon Soo
    LUNG CANCER, 2017, 110 : 63 - 67
  • [45] PD-L1 expression and its relationship with other driver genes in non-small cell lung cancer (NSCLC)
    Jiang, Liyan
    Su, Xinying
    Zhang, Tianwei
    Yin, Xiaolu
    Zhang, Meizhuo
    Fu, Haihua
    Han, Hulin
    Sun, Yun
    Dong, Lili
    Qian, Jialin
    Xu, Yanhua
    Fu, Xuan
    Gavine, Paul
    Zhou, Yanbin
    Kun, Tian
    Huang, Jiaqi
    Jiang, Haiyi
    Yao, Yihong
    Han, Baohui
    Gu, Yi
    CANCER RESEARCH, 2016, 76
  • [46] Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy
    Vrankar, Martina
    Kern, Izidor
    Stanic, Karmen
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [47] Accelerated neoadjuvant chemotherapy of non-small cell lung cancer (NSCLC)
    Lorusso, V
    Carpagnano, F
    diRienzo, G
    Catino, A
    Cisternino, ML
    Guida, M
    Brandi, M
    Latorre, A
    Parisi, S
    Ricco, R
    deLena, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (04) : 675 - 680
  • [48] Comparative study of two PD-L1 expression assays in patients with non-small cell lung cancer (NSCLC).
    Feng, Zheng
    Schlichting, Michael
    Helwig, Christoph
    Chand, Vikram K.
    Gelb, Arnold
    Jin, Hulin
    Grote, Hans Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] PD-L1-Gene Expression by nCounter Correlates with PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)
    Cabrera, C.
    Aguado, C.
    Teixido, C.
    Pare, L.
    Castellvi, J.
    Lopez, L.
    Marin, E.
    Bernal, X.
    Martinez, D.
    Gimenez-Capitan, A.
    Vinolas, N.
    Yeste, Z.
    Baixeras, N.
    Roman, R.
    Molina-Vila, M.
    Reguart, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S927 - S927
  • [50] Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy
    Martina Vrankar
    Izidor Kern
    Karmen Stanic
    Radiation Oncology, 15
12345